Henry Skinner
Articles
-
3 days ago |
infectioncontroltoday.com | Tori Whitacre Martonicz |Henry Skinner
Antimicrobial resistance (AMR) is escalating into a global health and economic crisis, threatening modern medicine’s foundations. In this exclusive interview, Henry Skinner, PhD, MBE, MJur, CEO of the AMR Action Fund, discusses the economic barriers to antibiotic innovation and outlines why traditional pharmaceutical models are failing.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →